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Ultrasensitive Measurement of Ca2+ Influx into Lipid Vesicles Induced
by Protein Aggregates
Patrick Flagmeier+, Suman De+, David C. Wirthensohn, Steven F. Lee, C8cile Vincke,
Serge Muyldermans, Tuomas P. J. Knowles, Sonia Gandhi, Christopher M. Dobson,* and
David Klenerman*
Abstract: To quantify and characterize the potentially toxic
protein aggregates associated with neurodegenerative diseases,
a high-throughput assay based on measuring the extent of
aggregate-induced Ca2+ entry into individual lipid vesicles has
been developed. This approach was implemented by tethering
vesicles containing a Ca2+ sensitive fluorescent dye to a passi-
vated surface and measuring changes in the fluorescence as
a result of membrane disruption using total internal reflection
microscopy. Picomolar concentrations of Ab42 oligomers
could be observed to induce Ca2+ influx, which could be
inhibited by the addition of a naturally occurring chaperone
and a nanobody designed to bind to the Ab peptide. We show
that the assay can be used to study aggregates from other
proteins, such as a-synuclein, and to probe the effects of
complex biofluids, such as cerebrospinal fluid, and thus has
wide applicability.
The conversion of soluble proteins into fibrillar amyloid
deposits is a hallmark of a range of increasingly prevalent
neurodegenerative disorders including AlzheimerQs Disease
(AD) and Parkinson Disease (PD).[1–4] It has been reported
that the species formed during the aggregation reactions have
a toxic effect on cells.[5–8] Several possible mechanisms of
cellular damage have been identified with relative contribu-
tions that depend on both the concentrations and the types of
aggregates present.[1–11] The aggregation process that results
in the formation of oligomers may contribute to cellular
damage.[12–15] Some of these mechanisms are thought to
involve specific binding to receptors on the cell mem-
brane[1,5, 9] while others appear to be the consequence of
non-specific membrane disruption.[1, 3, 5,9, 16] A body of data
suggests that small soluble aggregates, often called oligomers,
rather than mature fibrils, are able to cause the membrane to
become permeable to Ca2+ resulting in Ca2+ influx and the
disruption of Ca2+ homeostasis.[2,3, 5, 9, 17,18] Therefore, it is
important to quantify and characterize these species within
aggregation mixtures in vitro as well as to be able to perform
measurements in biological samples, such as cerebrospinal
fluid (CSF).[19] However, these oligomers are known to be
present at low abundance and to be highly heterogeneous in
nature, in terms of both their size and structure.[1–4, 9, 10,16]
Herein we describe the development and application of
a quantitative method based on the extent of disruption of
membranes by protein aggregates monitored by measure-
ment of the resulting Ca2+ entry into vesicles. Methods to
detect membrane disruption in bulk solution, based on
measuring dye leakage, are valuable for high mm concentra-
tions of toxic species,[20] but we utilize nanosized vesicles filled
with a dye whose fluorescence increases on binding Ca2+ ions.
The entry of a small number of Ca2+ ions into such small
volumes leads to a significant change in concentration,
enabling high resolution measurements to be made. For
example, if a single Ca2+ ion enters an individual vesicle with
a diameter of 200 nm, the concentration of Ca2+ will change
by approximately 400 nm, which can readily be detected using
highly sensitive fluorescence microscopy techniques. We
designed our assay to achieve an optimal combination of
sensitivity and dynamic range by preparing vesicles of an
appropriate diameter encapsulated with the optimal concen-
trations of the Ca2+ binding dye, Cal-520 (see Supporting
Information Note 1 and 2 and Supporting Information Fig-
ure S1). We immobilized thousands of single vesicles with
a diameter of 200 nm containing dye molecules on the glass
coverslides and imaged the Ca2+ influx into hundreds of
individual vesicles per field of view using total internal
reflection fluorescence microscopy (TIRFM; Figure 1, Fig-
ure S2). This method enables the detection of small changes
in the Ca2+ concentration on many vesicles in parallel leading
to a high degree of accuracy.
The vesicles used were composed of 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) and biotinylated POPC
(at a ratio of 100:1) filled with the Ca2+-sensitive Cal-520 dye
and prepared by extrusion.[21] To remove non-encapsulated
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dye molecules from the solution, size exclusion chromatog-
raphy was carried out (see Supporting Information, Fig-
ure S3) prior to tethering the vesicles onto PEG (PLL-g-
PEG: PLL-g-PEG-biotin 100:1) coated glass coverslides via
biotin-neutravidin linkages;[22–24] such a process has been
reported to maintain ion permeability,[22] spherical morphol-
ogy,[23] and membrane diffusivity[22] . The conditions were
chosen to generate a low coverage of vesicles on the surface
(ca. 1%), enabling single vesicles to be monitored individu-
ally and analyzed.
We incubated these immobilized vesicles in LeibovitzQs L-
15 medium containing Ca2+ at a concentration of 1.26 mm and
imaged them using TIRFM (Figure 1 (i) and (iv), Fblank).
Typically, we imaged 16 fields of view (on a 4 X 4 grid) for
each coverslide using a computer-controlled automatic micro-
scope stage, allowing the measurement of identical areas of
the coverslide (Figure S4). We then added a solution con-
taining the species of interest (e.g. protein aggregates) and re-
imaged the identical fields of view. If Ca2+ entered any given
vesicle, an increase in the localized fluorescence intensity
could be detected (Figure 1b (ii) and (v), Faggregate). The
fluorescence signals, before and after the addition of aliquots
of the solution, were stable with time (Figures S5–S7) and
hence the changes in the localized fluorescence can be
attributed to species that disrupt the vesicles. To quantify the
Ca2+ influx into individual vesicles, we added the cation
transporting ionophore, ionomycin (Figures S6,S8), which
allows Ca2+ to enter the vesicles to saturation. The maximum
fluorescence intensity of each vesicle was then measured
(Figure 1b (iii) and (vi), Fionomycin) and the percentage of Ca
2+
influx was calculated. This approach corrected for the fact
that the number of Cal-520 dye molecules in a vesicle is not
constant, owing to variations in the efficiency of dye
encapsulation[25] and in vesicle size. The fluorescence intensity
change was quantitatively converted into a percentage of Ca2+
influx for individual vesicles and then averaged over all the
vesicles imaged (Figure 1, see Supporting Information for
details).
We first carried out a series of experiments with solutions
of the recombinant Ab42 peptide (Figure 2a), under con-
ditions where the aggregation reaction has been found to be
highly reproducible.[26] Monomeric Ab42 was purified (t1),
and its addition to the vesicles resulted in no detectable
increase in fluorescence, indicating that the monomeric
protein does not induce Ca2+ influx (Figure 2b).
We then incubated 2 mm monomeric Ab42 at 37 8C and
took aliquots from the aggregation reaction corresponding to
the end of the lag-phase (t2). We detected an increase in the
localized fluorescence due to the influx of Ca2+ resulting from
the interaction of protein aggregates with the lipid bilayer.
The aliquots taken from the aggregation reaction mixture had
to be diluted 200 times to avoid saturation of individual
vesicles with Ca2+, highlighting the sensitivity of our method.
Note that oligomers of the Ab peptide have been reported to
be stable upon dilution[27] and we observed their ability to
induce Ca2+ influx into individual vesicles to remain constant
for up to 2 h after dilution (Figure S9). We also tested aliquots
corresponding to time points of an aggregation reaction at the
plateau phase (t3), by which time most of the monomeric
Figure 1. Quantitative high-throughput fluorescence imaging of Ca2+
ion influx into individual surface-tethered vesicles imaged using TIRF
microscopy. a) Individual vesicles filled with the fluorescent dye Cal-
520 are immobilized on a polymer-passivated (PLL-g-PEG/PLL-g-PEG-
biotin) glass cover slide through biotin-neutravidin tethering. Addition
of membrane-disrupting species (e.g. protein aggregates) leads to
Ca2+ influx into vesicles resulting in an increase in the localized
fluorescence intensity. b) Identical positions of the coverslides are
imaged under three different conditions, shown schematically (i)–(iii)
and as TIRF images (iv)–(vi). Images are acquired in the presence of
only Ca2+ buffer [(i) and (iv)], followed by the addition of protein
aggregates [(ii) and (v)], and then the addition of the ionophore
ionomycin [(iii) and (vi)]. The TIRF images were averaged over
50 frames with an exposure time of 50 ms each without further image
processing. Individual vesicles containing Cal-520 dye molecules
appear as localized bright spots under 488-nm illumination. In the
presence of Ca2+ buffer alone, the intensity of a vesicle is comparable
to that of the background due to no or minimal Ca2+ influx into the
vesicles. Addition and incubation with protein aggregates causes
a significant increase in the fluorescence of some of the vesicles and
subsequent addition of ionomycin results in saturation of all vesicles
by Ca2+, causing detection of a maximum value of the fluorescence
signal. All the images are shown with equal contrast. The scale bar:
3 mm. c) Ca2+ influx into 13 individual vesicles as shown in (b) (iv)–
(vi). The percentage of Ca2+ influx in each vesicle was calculated using:
(Faggregate@Fblank)*100/ (Fionomycin@F aggregate), where Fblank, Faggregate, Fionomycin
represent the fluorescence in the presence of Ca2+ containing buffer,
a solution containing protein samples (e.g. aggregates), and ionomy-
cin, respectively. d) Histogram showing the distribution of the percent-
age of Ca2+ influx into 744 individual vesicles after the addition of
aliquots taken from an aggregation reaction of Ab42 with an average
Ca2+ influx of 19.44%.
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protein had been converted into fibrils.[14] In this case, we
detected a much lower fluorescence increase compared to
that of aliquots of the sample taken at t2, although greater
than that of aliquots at t1.
The contents of the aggregation solutions are heteroge-
neous, with the protein being present in monomeric and
aggregated forms.[3, 4] To determine the nature of the species
of the protein causing Ca2+ influx we employed size exclusion
chromatography to separate species of different size[14]
produced at the end of the lag-phase (t2). We then probed
the fluorescence changes arising from Ca2+ influx caused by
the different fractions (Figure 2c). We observed no detectable
change in fluorescence with the fractions containing only
monomeric protein (elution volume 16 mL), indicating that
this species is not the component of the mixture causing Ca2+
ion influx. By contrast we observed a substantial level of
fluorescence from the vesicles after the addition of those
fractions that contain species of higher molecular weight than
the monomeric protein, indicating that the observed Ca2+
influx is caused by Ab42 oligomers.
To characterize the dynamic range and sensitivity of this
assay we measured the dependence of the Ca2+ influx on the
Ab42 concentration, by carrying out a series of dilution
experiments on a sample taken from an Ab42 solution at
a time point corresponding to t2. We found a linear depend-
ence of the change in the fluorescence intensity caused by
Ab42 in the concentration range from 0 to 800 pm monomer
equivalents, but noticed that the observed Ca2+ influx
saturated at higher concentrations of Ab42 (Figure 2d). The
method, therefore, enables us to measure quantitatively and
reproducibly the Ca2+ influx induced by protein aggregates at
picomolar concentrations (Figure S10,S11).
Next, we explored the potential of our method to test the
effectiveness of two types of macromolecules, both of which
have been attributed to bind to aggregated forms of Ab42, in
preventing the influx of Ca2+ ions. This approach has potential
value for screening inhibitors in the search for effective
therapeutic agents. We here studied the ability of the
extracellular chaperone clusterin,[28] and the nanobody
Nb3,[29] to reduce oligomer induced Ca2+ influx using aliquots
taken from the Ab42 aggregation reaction at time t2. We then
diluted this solution containing pre-formed oligomers to
a concentration of 10 nm Ab42 (monomer equivalents) and
added 200 nm clusterin or 200 nm Nb3, respectively, both of
which have been reported to bind to the Ab peptide.[28, 29] We
incubated the samples for 15 min before assessing the ability
of the excess concentrations of clusterin and Nb3 to counter-
act the membrane permeation caused by Ab42 oligomers
(Figure 3a, see Supporting Information). We observed that
both species reduced very significantly the degree of Ca2+
influx while incubationwith an anti-GFP antibody, as a control
that does not bind to the Ab peptide, had no detectable effect.
These results are consistent with previous reports that
clusterin[30, 31] and Nb3 bind to oligomers of the Ab peptide,
resulting in the reduction of Ca2+ influx into neuronal
cells.[7,11] We then carried out a series of dilution experiments
to find the concentration required to reduce the Ca2+ influx by
half; we obtained values of 0.1: 0.02 nm and 18: 3.4 nm for
clusterin and Nb3, respectively (Figure 3b,c). To our knowl-
edge there is no reported value of the binding affinity of
clusterin for Ab42, but the off-rate when bound to aggregates
has been found to be very slow[27] consistent with the tight
binding observed in our experiments. The dissociation con-
stant for Nb3 binding to monomeric Ab42 has been reported
to be 13 nm,[29] a value comparable to that measured in the
present study, suggesting there is no significant reduction in
the accessibility of the epitope in the oligomeric species.
In an additional series of experiments, we have shown that
the methodology can also be applied to the study of other
proteins whose aggregation is associated with neurodegener-
ative conditions. We incubated a-synuclein, the 140 residue
natively unstructured protein whose aggregation is associated
with PD, under conditions where it has previously been found
to form oligomeric species, and observed a change in the
fluorescence intensity (Figure S12) of individual vesicles
similar to that described above for Ab42.[18, 32]
We also examined the degree of Ca2+ influx induced by
recombinant Ab42 aggregates in the presence of a complex
biological environment, such as CSF, which contains a multi-
Figure 2. Ca2+ influx caused by aggregates of the Ab42 peptide.
a) Kinetic profile of Ab42 aggregation under quiescent conditions at
a concentration of 2 mm protein. The time points correspond to the
start of the aggregation reaction (t1), the end of the lag-phase (t2), and
the plateau phase (t3), at each of which an aliquot was taken and
diluted to a concentration of 5 nm (monomer equivalents). b) Ca2+
influx induced by an aggregation mixture at time points t1, t2, and t3 ;
a Ca2+ influx of 100% corresponds to the Ca2+ influx caused by
ionomycin. c) Size exclusion chromatography of an aliquot taken at t2
and the degree of Ca2+ influx induced by different elution volumes was
then tested. Oligomeric forms of the protein were found to elute at
volumes of 7 to 12 mL and monomeric protein at a later elution
volume of 14 to 17 mL. d) The dependence of Ca2+ influx on the total
concentration of Ab42 (in monomer equivalents) measured by serial
dilution of an aliquot taken at t2. The error bars represent variations
between different fields of view and the data correspond to averages
over measurements of more than 700 vesicles. Inset: expansion of the
low concentration region.
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tude of different proteins and other macromolecules.[33, 34] We
took aliquots of an Ab42 aggregation reaction at the time
point corresponding to t2 and added them at varying concen-
trations to the human CSF of one individual (Figure S13). We
observed an increase in the measured Ca2+ influx with Ab42
concentrations of 100 pm and above. These results demon-
strate that our method is sufficiently sensitive to measure the
Ca2+ influx caused by protein aggregates at low concentra-
tions in the presence of a complex human biofluid. Only small
volumes of CSF were used in each experiment, 15 mL,
allowing multiple measurements on a typical sample of CSF
with a volume of 1 mL.
In conclusion, we have demonstrated that our single-
vesicle assay identifies oligomers as the form of protein
aggregates in the complex aggregation mixtures of Ab42 that
cause Ca2+ influx. It also allows the extent of Ca2+ influx
caused by aggregates in a sample to be quantified, which
serves as a measure of the ability of aggregates to disrupt
membrane integrity. The method also enables the effective-
ness of reagents to reduce aggregate-induced Ca2+ influx to be
measured and can be applied directly to other proteins, such
as a-synuclein, and also to complex biofluids. The misfolding
and aggregation of proteins has been associated with approx-
imately fifty misfolding diseases[35] for which our assay might
be directly employed. Thus, application of the single-vesicle
assay to the field of protein misfolding diseases may greatly
help global efforts to identify the pathogenic forms of proteins
and to assist in the development of therapeutic agents to treat
these currently incurable conditions. More broadly the assay
can be exploited to study quantitatively in a high-throughput
manner any biochemical process that allows ions to enter
vesicles across the lipid bilayer.
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